Skip to main content
. 2022 May 16;14(10):2454. doi: 10.3390/cancers14102454

Figure 1.

Figure 1

Oncoprint illustrating genomic aberrations observed in 104 patients with glioma using a comprehensive genomic profiling test (CGPT). The top 30 most frequently reported genes are displayed, and their type of genomic aberrations are categorized as follows by their colors: Deletion, Amplification, Missense mutation, Truncating mutation, Inframe mutation, Fusion, Splice, Other Structural Variant, and TERT promoter mutation. The number of genomic aberrations for each case and gene is displayed at the middle row and the right of the oncoprint, respectively. At the top, the tumor mutation burden (TMB, [mutations/Mb]) score for each patient is shown. ID for each patient is shown at the bottom. For the cases with an unavailable TMB score, TMB is shown as −1. See also Figure S1A. for a full genomic display.